Keck Biotechnology Lab

Keck Mass Spectrometry Resource

Yale/NHLBI Proteomics Center

High Performance Computation

Yale Neuroscience Microarray Center

 

Site Index:


Yale/NIDA
Proteomics Center


Yale University
300 George Street
New Haven, CT 06511


Contact Us

   Yale University School of Medicine

NIDA Proteomics Center InvestigatorsPaul Greengard

The Role of miRNAs in Neuronal Cell Survival and Function
Paul Greengard, Laboratory of Molecular and Cellular Neuroscience,
The Rockefeller University

Understanding of the molecular mechanisms of drug addiction is essential for the development of novel approaches for the treatment of this debilitating disease. Recent findings showed that development of addictive behavior in mice is associated with stable changes in gene and protein expression. We found that establishment of cocaine addiction in mice is associated with expression changes of numerous miRNAs in the striatum, a brain area responsible for drug addiction. Given the potent role of miRNAs in regulation of protein expression, we hypothesize that cocaine-regulated miRNAs contribute to the establishment of the protein expression network that supports addiction. To evaluate the contribution of cocaine induced miRNAs to the development and maintenance of cocaine addiction we propose to address the impact of striatum specific alteration of individual miRNAs on addiction. We will test whether correction of miRNA levels affected by chronic cocaine treatment affects the development of addictive behavior in vivo. Additionally, we will attempt to identify the striatal targets of individual miRNAs using a proteomic approach. Inactivation of miRNA that are induced by cocaine treatment will be achieved by injection of the RNA based cell-permeable specific miRNA inhibitors into the striatum. In turn, striatum specific normalization of miRNA that are suppressed by cocaine will be achieved by using miRNA expressing adeno-associated virus (AAV). Identification of specific miRNAs and their targets that play a role in the development and maintenance of cocaine addiction may help to reveal the molecular networks controlling dopamine signaling in health and disease. Furthermore, targeting of the addiction-associated miRNAs by synthetic miRNA antagonists may lead to development of novel and highly specific approach for treatment of addiction.


    Top of Page
Medical Center

Yale-New Haven Hospital

Yale University

Copyright © 2004 - 2006, Yale University, New Haven, Connecticut, USA. All rights reserved.
Comments or suggestions to Greg Blasko.

Last modified: 23-May-2008 (GB)